Related Experiment Video
Updated: Feb 27, 2026
08:36
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.5K
A clinical advancement program: evaluating 10 years of progressive change
M Krugman1, K Smith, C J Goode
1Department of Patient Services, University of Colorado Hospital, Denver, USA. Mary.Krugman@UH-Colorado.edu
The Journal of Nursing Administration
|May 24, 2000
Summary
The UEXCEL clinical advancement program showed steady improvement in nurse satisfaction over time, especially after revisions. Higher registered nurse education correlated with greater program satisfaction, highlighting key factors for success.
Area of Science:
- Nursing Professional Development
- Healthcare Program Evaluation
- Clinical Ladder Programs
Background:
- The UEXCEL clinical ladder program, established in 1989, provides a framework for registered nurse (RN) development, evaluation, and promotion.
- Based on Benner's Novice to Expert model, the program has undergone three major revisions over a decade.
- Program evaluation data have been instrumental in driving institutional change and program refinement.
Purpose of the Study:
- To document the evolution of the UEXCEL clinical advancement program.
- To assess the outcomes of the UEXCEL program's evaluation over time.
- To identify factors influencing nurse satisfaction within a clinical advancement program.
Main Methods:
- Outlined the structure and progression of the UEXCEL program's development and changes.
- Collected evaluation data using a 23-item satisfaction scale in 1993, 1994, 1996, and 1998.
- Analyzed data from registered nurses at the University of Colorado Hospital, trending across units and time periods.
Main Results:
- Demonstrated steady, incremental improvement in nurse satisfaction with the UEXCEL program from a low baseline.
- Observed increased satisfaction following each program revision.
- Identified a significant correlation between higher registered nurse education levels and increased program satisfaction.
Conclusions:
- Sustaining clinical advancement programs is challenging in the current healthcare landscape.
- Institutional commitment and staff involvement in revisions are crucial for program success.
- Activities promoting professional nurse development are vital for achieving progress in clinical advancement programs.
More Related Videos
06:05The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
1.8K
09:19Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
26.4K
Related Concept Videos
01:11Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
01:16Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
01:28Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
01:26Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K
01:15Nursing Evaluation
4.6K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
4.6K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K